Viatris Inc.

    Jurisdiction
    United States
    LEI
    254900ZZTSW7NL773X71
    ISIN
    US92556V1061 (VTRS)
    Sectors
    1. Healthcare
    2. Drug Manufacturers - Specialty & Generic

    Scores

    InsiderPie Expert Score
    50 / 100
    Even with peer group:
    51 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    4 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    1 / 7

    Profile

    Viatris Inc. operates as a healthcare company worldwide. Read full profile

    Fundamentals

    Net revenue
    €12.21B
    Gross margin
    37.2%
    EBIT
    -€2.62B
    EBIT margin
    -21.5%
    Net income
    -€3.23B
    Net margin
    -26.5%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €12.05B -1.3% €2.41B -174.4%
    €12.24B +1.6% €2.53B +5.2%
    N/A N/A

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    $0.12
    Ex date
    Payment date

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Smith Scott Andrew Chief Executive Officer +22K $9.99 +$219.78K

    Congress transactions

    Name Transaction date Value
    Robert Bresnahan May 8, 2025 $1.00K–$15.00K
    Gilbert Cisneros April 7, 2025 $1.00K–$15.00K
    Robert Bresnahan March 27, 2025 $1.00K–$15.00K

    Earnings Calls

    Investor transactions

    Name Shares Value Last change Change type
    Ray Dalio 611K $5.32M -1.7M Sell

    Earnings Calls

    Latest earnings call: May 9, 2024 (Q1 2024)

    Add to watchlist

    Notifications